Company Filing History:
Years Active: 2013
Title: The Innovations of Kari Sweeney
Introduction
Kari Sweeney is an accomplished inventor based in Stamford, CT. She has made significant contributions to the field of immunology through her innovative research and patents. Her work focuses on mycobacterial mutants and their potential applications in vaccine development.
Latest Patents
Kari Sweeney holds a patent for "Mycobacterial mutants inducing IL-12." This patent includes mycobacteria that are deleted in at least a portion of a region 3 ESAT-6-like gene cluster. Additionally, it covers mycobacteria that comprise a mutation in an roc-1 gene. The patent also provides methods for making a recombinant, inducing an immune response in a mammal, inhibiting IL-12 production, and stimulating IL-12 production in a mammal. Furthermore, it includes vaccine adjuvants and methods for inducing immunity to a target antigen in a mammal.
Career Highlights
Kari Sweeney is affiliated with the Albert Einstein College of Medicine, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential impact on vaccine efficacy and immune response.
Collaborations
Kari collaborates with notable colleagues, including William R. Jacobs, Jr. and Dee Dao, who contribute to her research endeavors and enhance the scope of her work.
Conclusion
Kari Sweeney's innovative contributions to immunology through her patent on mycobacterial mutants highlight her role as a leading inventor in the field. Her work has the potential to advance vaccine development and improve immune responses in mammals.